Dechra Pharmaceuticals PLC Stock price

Equities

DPH

GB0009633180

Market Closed - London S.E. 02:30:00 2024-01-16 am EST 5-day change 1st Jan Change
3,866 GBX -.--% Intraday chart for Dechra Pharmaceuticals PLC -.--% +0.21%
Sales 2022 682M 861M Sales 2023 762M 961M Capitalization 4.2B 5.3B
Net income 2022 58M 73.22M Net income 2023 -27M -34.09M EV / Sales 2022 5.8 x
Net Debt 2022 208M 263M Net Debt 2023 430M 543M EV / Sales 2023 6.08 x
P/E ratio 2022
64.8 x
P/E ratio 2023
-150 x
Employees -
Yield 2022
1.3%
Yield 2023
0.34%
Free-Float 0%
More Fundamentals * Assessed data
Dynamic Chart
3 months+0.21%
6 months+1.84%
Current year+0.21%
More quotes
Current year
3 853.34
Extreme 3853.3425
3 868.00
1 year
2 582.00
Extreme 2582
4 145.84
3 years
2 473.32
Extreme 2473.323
5 525.00
5 years
2 030.00
Extreme 2030
5 525.00
10 years
655.00
Extreme 655
5 525.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 63 97-06-12
Director of Finance/CFO 44 09-12-31
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Chief Executive Officer 63 97-06-12
Director/Board Member 59 22-12-31
Chairman - 20-02-29
More insiders
Dechra Pharmaceuticals PLC specializes in the manufacturing and marketing of veterinary pharmaceutical products. Net sales break down by family of products as follows: - companion animal products (74.6%); - food producing animal products (11.5%); - equine health products (7.3%); - animal feeds (5.1%); - other (1.5%): products manufactured by third parties. Net sales are distributed geographically as follows: the United Kingdom (8.5%), Germany (9.2%), Europe (31.2%), the United States (37.9%) and other (13.2%).
Sector
-
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
  1. Stock
  2. Equities
  3. Stock Dechra Pharmaceuticals PLC - London S.E.